Home » Topics » BioWorld Science, Biomarkers

BioWorld Science, Biomarkers
RSS

mtm Laboratories launches Cervatec assay for cervical cancer

Feb. 7, 2008

Decreased VLDLR expression may be a biomarker for schizophrenia

Jan. 22, 2008

New role for endogenous microRNAs in cancer metastasis discovered

Jan. 16, 2008

Amic enters license agreement with Roche Diagnostics for test for cardiac marker NT-proBNP

Jan. 4, 2008

HealthLinx successfully completes phase II biomarker trial on the OvPlex panel

Nov. 20, 2007

Panacea makes CC Detect available as diagnostic test for colon cancer

Nov. 20, 2007

bioMerieux receives FDA clearance for sepsis biomarker assay

Oct. 24, 2007

AMDL seeks FDA approval for ELISA tumor marker test

Oct. 18, 2007

Polyunsaturated fatty acid erythrocyte content, biomarker of colorectal cancer risk

Oct. 15, 2007

HealthLinx initiates phase II biomarker trial of Ovplex test for ovarian cancer

Aug. 21, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 26, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026